Elekta (OTCMKTS:EKTAY) Sees Unusually-High Trading Volume – Time to Buy?

Elekta AB (OTCMKTS:EKTAY) saw strong trading volume on Thursday . Approximately 8,873 shares were traded during mid-day trading, an increase of 209% from the previous session’s volume of 2,867 shares.The stock last traded at $5.08 and had previously closed at $5.1950.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 28th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Elekta currently has a consensus rating of “Hold”.

Elekta Stock Down 2.2%

The company’s 50 day moving average price is $5.27 and its two-hundred day moving average price is $5.59. The company has a current ratio of 0.87, a quick ratio of 0.68 and a debt-to-equity ratio of 0.47. The stock has a market cap of $1.87 billion, a P/E ratio of -42.33 and a beta of 1.05.

Elekta (OTCMKTS:EKTAY) last released its quarterly earnings data on Thursday, August 27th. The company reported $0.07 earnings per share for the quarter. The firm had revenue of $372.30 million during the quarter. Elekta had a positive return on equity of 13.31% and a negative net margin of 2.38%. Equities analysts forecast that Elekta AB will post 0.43 earnings per share for the current year.

Elekta Company Profile

Elekta AB is a Sweden-based medical technology company focused on radiation oncology and precision treatment solutions. The company develops and supplies systems used to diagnose, plan and deliver treatments for cancer and other conditions affecting the brain and nervous system.

Its product portfolio includes linear accelerators for external-beam radiotherapy, stereotactic radiosurgery systems such as Leksell Gamma Knife, brachytherapy equipment and treatment-planning, oncology information and workflow software.